SII commences shipments of malaria vaccine 'R21/Matrix-M' to Africa

Serum Institute of India (SII) commenced exporting the 'R21/Matrix-M' malaria vaccine to Africa in collaboration with the University of Oxford and Novavax. The initial shipment, directed to the Central African Republic, is part of efforts to combat malaria in endemic regions, with further doses earmarked for South Sudan and the Democratic Republic of Congo.